Anzeige
Mehr »
Dienstag, 30.06.2026 - Börsentäglich über 12.000 News
China kontrolliert Seltene Erden - Brasilien könnte die Antwort sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
456 Leser
Artikel bewerten:
(2)

Diagnostic Orders Direct Launches Affordable $40 Virtual Diagnostic Order Consultations Across 30 States

LAS VEGAS, NV / ACCESS Newswire / May 20, 2026 / Diagnostic Orders Direct has launched a patient-focused telehealth service designed to make diagnostic order consultations more affordable, accessible, and convenient for patients across 30 states and jurisdictions. The service offers $40 virtual consultations for patients seeking provider review for diagnostic imaging, EKGs, laboratory testing, and specialist referral needs.

Diagnostic Orders Direct was created for patients who need help moving forward with non-emergency diagnostic care but may be delayed by traditional appointment wait times, confusing referral requirements, or uncertainty about which type of order is needed. Many imaging centers, laboratories, and diagnostic facilities require a provider order before scheduling services such as MRI, CT scan, X-ray, ultrasound, mammogram, EKG, or blood and urine testing. Diagnostic Orders Direct gives patients a practical way to request a licensed provider review through a simple phone or video consultation.

The company's model is built around affordability and access. Each virtual consultation is offered at a flat rate of $40, with no membership, subscription, or hidden fee structure. Diagnostic Orders Direct also works with lab partners to offer competitive pricing for common blood and urine laboratory testing when appropriate. This can be especially helpful for self-pay patients, patients with high-deductible insurance plans, or patients who want transparent pricing before moving forward with diagnostic testing.

Diagnostic Orders Direct offers daily appointment availability, including late-hour scheduling options, to help accommodate patients who may not be able to schedule during traditional business hours. The service is designed for convenience while still keeping medical appropriateness, provider judgment, and patient safety at the center of every order.

Diagnostic Orders Direct has also seen strong patient interest driven by convenience, affordability, and ease of access. Many patients who use the service find themselves recommending Diagnostic Orders Direct to friends, family members, and acquaintances who are also looking for a practical starting point for imaging orders, lab testing, EKG requests, or specialist referral guidance. The company believes this word-of-mouth growth reflects the need for a more accessible diagnostic order consultation option that is simple, affordable, and available beyond traditional appointment hours.

"We wanted to create a service that is affordable, direct, and available when patients actually need it," a company representative said. "Many patients already know they need help getting the next step started, whether that is imaging, lab work, an EKG, or a referral. Our role is to provide a licensed provider review, determine whether the request is medically appropriate, and help patients move forward responsibly."

Through the platform, patients complete an intake form and meet virtually with a licensed medical provider by phone or video. The provider reviews the patient's symptoms, medical history, prior testing, requested study, and diagnostic concerns. When clinically appropriate, the provider may issue orders for diagnostic services such as MRI, CT scan, X-ray, ultrasound, PET scan, mammogram, MRA, CTA, EKG, blood testing, or urine testing. When appropriate, the service may also help facilitate referral to a medical specialist.

If an order is issued, patients may generally take the order to the diagnostic facility, imaging center, laboratory, or testing location of their choice, depending on facility requirements and state-specific rules. This flexibility may benefit patients seeking self-pay imaging, cash-pay lab work, second-step diagnostic evaluation, or testing required before seeing a specialist.

Diagnostic Orders Direct may be useful for patients seeking non-emergency review for musculoskeletal imaging, injury-related imaging requests, follow-up testing, screening-related orders, EKG requests, blood work, urine testing, or referral guidance. The service may also help patients who have already spoken with an imaging center or lab and were told that a provider order is required before scheduling.

The company emphasizes that diagnostic orders are not guaranteed. All orders are issued only when medically appropriate after provider review. Providers may recommend a different test, advise in-person evaluation, suggest primary care follow-up, refer the patient to urgent care, or direct the patient to emergency services when clinically necessary.

Diagnostic Orders Direct is not an imaging center, laboratory, emergency service, or replacement for ongoing primary care. Patients experiencing emergency symptoms, including chest pain, stroke-like symptoms, severe shortness of breath, major trauma, severe abdominal pain, sudden neurological changes, severe allergic reactions, or other urgent medical concerns, should call 911 or go to the nearest emergency room.

Service Area

Diagnostic Orders Direct currently serves patients in the following states and jurisdictions: Alaska, Arizona, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Idaho, Iowa, Kansas, Maine, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oklahoma, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wyoming.

The company continues to evaluate expansion opportunities as demand for affordable, accessible diagnostic order consultations grows. Its goal is to reduce confusion, improve access, and give patients a straightforward starting point for appropriate diagnostic care.

Patients may call, text, or visit the Diagnostic Orders Direct website to schedule a $40 virtual diagnostic order consultation.

Media Contact:

Jordan Dorsey
Diagnostic Orders Direct
+1 702-588-3455
customerservice@diagnosticordersdirect.com
https://diagnosticordersdirect.com/

SOURCE: Diagnostic Orders Direct



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/diagnostic-orders-direct-launches-affordable-40-virtual-diagnost-1168455

© 2026 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.